Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Total Non-Current Liabilities (2018 - 2025)

AVITA Medical (RCEL) has disclosed Total Non-Current Liabilities for 5 consecutive years, with $71.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities changed 0.37% year-over-year to $71.8 million, compared with a TTM value of $71.8 million through Dec 2025, changed 0.37%, and an annual FY2025 reading of $71.8 million, changed 0.37% over the prior year.
  • Total Non-Current Liabilities was $71.8 million for Q4 2025 at AVITA Medical, up from $68.5 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $71.8 million in Q4 2025 and bottomed at $8.1 million in Q1 2022.
  • Average Total Non-Current Liabilities over 4 years is $52.2 million, with a median of $63.7 million recorded in 2024.
  • The sharpest move saw Total Non-Current Liabilities surged 405.49% in 2023, then rose 0.37% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $11.6 million in 2022, then soared by 405.49% to $58.7 million in 2023, then increased by 21.8% to $71.5 million in 2024, then rose by 0.37% to $71.8 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for RCEL at $71.8 million in Q4 2025, $68.5 million in Q3 2025, and $69.1 million in Q2 2025.